The review presents AMPK as a central metabolic checkpoint that can influence cancer cell proliferation and stress responses. It is discussed as a therapeutic target rather than as a discrete toolkit component.
First-pass extracted concept
AMPK in cancer
Aliases
AMP-activated protein kinase in cancer, AMPK as an anticancer target
Extracted Explainers
What the tool is doing
What problem it solves
What it does not solve
Evidence Snippets
Adenosine monophosphate-activated protein kinase (AMPK) is a key player in maintaining energy homeostasis in response to metabolic stress. Beyond diabetes and metabolic syndrome, there is a growing interest in the therapeutic exploitation of the AMPK pathway in cancer treatment...
Supporting Sources
Linked Claims
The role of AMPK in cancer is context dependent, with literature supporting both tumor-suppressive effects and survival-promoting effects under stress or oncogenic signaling.
AMPK is a key regulator of energy homeostasis during metabolic stress and is being explored as a therapeutic pathway in cancer because it can regulate cancer cell proliferation through metabolic reprogramming.
AMPK activation can inhibit tumor growth by targeting multiple signaling pathways relevant to tumorigenesis.
AMPK may function downstream of oncogenic proteins including androgen receptor, HIF1α, c-Src, and MYC in some cancer contexts.
Under certain cellular contexts or stages of tumor development, AMPK can act as a protective response to metabolic stresses such as nutrient deprivation, low oxygen, and low pH.
Whether AMPK activation or AMPK inhibition is the more relevant cancer treatment strategy likely depends on tumorigenic stage and genetic context.